Hemagglutinating virus of Japan‐envelope containing programmed cell death‐ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma-Reference-Cited by-同舟云学术

Hemagglutinating virus of Japan‐envelope containing programmed cell death‐ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma

Published:2020-11-25 Issue:1 Volume:112 Page:81-90
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Sugii Narushi¹²,Matsuda Masahide¹^ORCID,Okumura Genki³⁴,Shibuya Akira³⁵,Ishikawa Eiichi¹,Kaneda Yasufumi⁶,Matsumura Akira¹

Affiliation:

1. Department of Neurosurgery Faculty of Medicine University of Tsukuba Ibaraki Japan

2. Majors of Medical Sciences Graduate School of Comprehensive Human Sciences University of Tsukuba Ibaraki Japan

3. Department of Immunology Faculty of Medicine University of Tsukuba Ibaraki Japan

4. Majors of Biomedical Sciences Graduate School of Comprehensive Human Sciences University of Tsukuba Ibaraki Japan

5. Life Science Center for Survival Dynamics Tsukuba Advanced Research Alliance (TARA) R&D Center for Innovative Drug Discovery University of Tsukuba Ibaraki Japan

6. Division of Gene Therapy Science Department of Genome Biology Graduate School of Medicine Osaka University Osaka Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14721

Reference42 articles.

1. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma

2. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

3. Hallmarks of Cancer: The Next Generation

4. Harnessing the immune system in glioblastoma

5. The Microenvironmental Landscape of Brain Tumors

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in biomimetic strategies for the immunotherapy of glioblastoma;Biomaterials;2024-12

2. Reprogramming tumor-associated macrophages by a dually targeted milk exosome system as a potent monotherapy for cancer;Journal of Controlled Release;2024-02

3. Viral Vectors Expressing Interleukin 2 for Cancer Immunotherapy;Human Gene Therapy;2023-09-01

4. Advances in NK cell therapy for brain tumors;npj Precision Oncology;2023-02-15

5. Unleashing the Potential of Natural Killer Cells in Immunotherapy for Glioblastoma and Brain Tumors;Interdisciplinary Cancer Research;2023